Medical technology company Teleflex (NYSE: TFX) will be reporting results tomorrow morning. Here’s what investors should know.
Teleflex missed analysts’ revenue expectations by 2.3% last quarter, reporting revenues of $795.4 million, up 2.8% year on year. It was a softer quarter for the company, with a miss of analysts’ constant currency revenue estimates.
Is Teleflex a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Teleflex’s revenue to decline 5.3% year on year to $699 million, a reversal from the 3.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.88 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Teleflex has missed Wall Street’s revenue estimates three times over the last two years.
Looking at Teleflex’s peers in the healthcare equipment and supplies segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Intuitive Surgical delivered year-on-year revenue growth of 19.2%, beating analysts’ expectations by 3.1%, and Penumbra reported revenues up 16.3%, topping estimates by 2.7%. Intuitive Surgical traded up 1.9% following the results while Penumbra was also up 7.2%.
Read our full analysis of Intuitive Surgical’s results here and Penumbra’s results here.
Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the healthcare equipment and supplies stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.6% on average over the last month. Teleflex is down 1.4% during the same time and is heading into earnings with an average analyst price target of $161.82 (compared to the current share price of $138.30).
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
